ARCHITECT INSULIN 08K41-26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2016-08-11 for ARCHITECT INSULIN 08K41-26 manufactured by Abbott Laboratories.

Event Text Entries

[51938007] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete. Patient identifier whole sid (b)(6). An evaluation is in process.
Patient Sequence No: 1, Text Type: N, H10


[51938008] The customer observed falsely elevated insulin patient results generated using the architect insulin reagents. The following data was provided (uu/ml). Sid (b)(6) result 72. 80. Previous results for the patient were provided, 27. 4, 34. 7. Dilution linearity testing results ranged from 21. 60 to 28. 80. The patient is an (b)(6) weighing less than (b)(6). The mother of the (b)(6) is a diabetic patient. No impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[54058826] Evaluation of the customer issue included a review of the complaint text, a search for similar complaints, a review of field data, a review of labeling, and accuracy testing. No adverse trend was identified for the customer's issue. Review of field data found the complaint lot performance was comparable to other lots, and no issue was found. Labeling was reviewed and found to be adequate. Device history review did not identify any issues that may have caused the customer issue. The product was not available for return. An internal panel was tested with retained kits of the likely cause reagent lot and accuracy testing met all specifications. Based on all available information and abbott diagnostics complaint investigation, the assay performed as intended and no product deficiency was identified.
Patient Sequence No: 1, Text Type: N, H10


[75540117] The device evaluation was reassessed and concluded that a malfunction occurred, the device did not perform as intended. However, no systematic issue or product deficiency was identified.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2016-00082
MDR Report Key5869475
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2016-08-11
Date of Report2017-05-09
Date Mfgr Received2017-05-09
Device Manufacturer Date2016-01-01
Date Added to Maude2016-08-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 600643500
Manufacturer CountryUS
Manufacturer Postal Code600643500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT INSULIN
Generic NameINSULIN
Product CodeCFP
Date Received2016-08-11
Catalog Number08K41-26
Lot Number61020LP77
Device Expiration Date2016-11-17
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 600643500 US 600643500


Patients

Patient NumberTreatmentOutcomeDate
10 2016-08-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.